Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
09/2014
09/17/2014EP2776393A1 Nampt inhibitors
09/17/2014EP2776070A1 Immunomodulatory conjugates
09/16/2014US8835613 β-mannosylceramide and stimulation of NKT cell anti-tumor immunity
09/16/2014US8835435 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
09/16/2014US8835430 2,4-pyrimidinediamine compounds and their uses
09/16/2014US8834900 Combination motif immune stimulatory oligonucleotides with improved activity
09/16/2014US8834897 Methods for using tetanus toxin for beneficial purposes in animals (mammals)
09/16/2014CA2752569C .delta.-amino acid as an exercise function-improving agent
09/16/2014CA2650970C P38 map kinase inhibitors
09/16/2014CA2624081C Method of identifying membrane ig specific antibodies and use thereof for targeting immunoglobulin-producing precursor cells
09/16/2014CA2545806C Methods of modulating immunity
09/16/2014CA2510309C Recombinant vaccine viruses expressing il-15 and methods of using the same
09/16/2014CA2454644C Cannabinoid liquid formulations for mucosal administration
09/15/2014CA2809714A1 Infectious genomic dna clone and serological profile of torque teno sus virus 1 and 2
09/12/2014WO2014136814A1 Novel peptide having 5 linked ctl epitopes
09/12/2014WO2014135244A1 Triazolo[4,5-d]pyrimidine derivatives for the treatment of diseases such as cancer
09/12/2014WO2014134830A1 Edible composition, food product comprising same, and preparation method for the food product
09/12/2014WO2014134698A1 Cpg oligonucleotide formulations and methods and uses thereof
09/11/2014US20140256652 Polypeptides Involved In Immune Response
09/11/2014US20140255497 Organic Compounds
09/11/2014US20140255493 Extrudate and methods of using said extrudate
09/11/2014US20140255396 Multiple-variable dose regimen for treating tnfalpha-related disorders
09/10/2014EP2774920A1 Crystalline forms of 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt and their medical use
09/10/2014EP2773754A1 Method of treatment
09/10/2014EP2773671A1 Stable heterodimeric antibody design with mutations in the fc domain
09/10/2014EP2773645A1 Imidazopyridazine compounds
09/10/2014EP2773640A1 Bicyclic piperazine compounds
09/10/2014EP2773639A1 Alkylated piperazine compounds as inhibitors of btk activity
09/10/2014EP2773638A1 Heteroaryl pyridone and aza-pyridone compounds as inhibitors of btk activity
09/10/2014EP2773632A1 8-fluorophthalazin-1 (2h) - one compounds as inhibitors of btk activity
09/10/2014EP2773371A1 Effect of an attenuated bordetella strain against allergic disease
09/09/2014US8828973 Compounds as receptor modulators with therapeutic utility
09/09/2014US8828947 Polypeptide formulation
09/09/2014US8828669 Methods of screening for a compound that inhibits the interaction between BAFF and BCMA
09/09/2014US8828446 Method for reducing transplant rejection in the eye and intraocular implants for use therefor
09/09/2014US8828406 Influenza viruses and uses thereof
09/09/2014US8828405 Method to enhance an immune response of nucleic acid vaccination
09/09/2014US8828359 Particulate materials
09/04/2014WO2014134388A1 Phenylpyrazole derivatives as potent rock1 and rock2 inhibitors
09/04/2014WO2014134355A1 Drug combinations
09/04/2014WO2014132100A1 Mobilizing agents and uses therefor
09/04/2014US20140249092 Cyclosporin analog formulations
09/04/2014US20140248700 Method of Differentiation of Morula or Inner Cell Mass Cells and Method of Making Lineage-Defective Embryonic Stem Cells
09/04/2014US20140248661 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use
09/04/2014US20140248277 Multiple-variable dose regimen for treating tnfalpha-related disorders
09/04/2014US20140248276 Multiple-variable dose regimen for treating tnfalpha-related disorders
09/04/2014US20140248275 Multiple-variable dose regimen for treating tnfalpha-related disorders
09/03/2014EP2772486A1 Kinase inhibitor and method for treatment of related diseases
09/03/2014EP2771329A1 Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
09/03/2014EP2771069A2 Inhibiting g protein coupled receptor 6 kinase polypeptides
09/03/2014EP2770986A1 Apparatus and method for producing controlled dosage of bioactive agent
09/03/2014EP2770854A1 Allergy treatment with non- digestible oligosaccharide
09/02/2014US8822685 2,4-pyrimidinediamine compounds and their uses
09/02/2014US8822481 Salts of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d] pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
09/02/2014US8822169 HMG1 antibody for treating inflammatory conditions
09/02/2014US8821889 West Nile Virus vaccine
09/02/2014US8821885 Immunogenic compositions and methods
09/02/2014US8821883 Method of treating B cell cancers by administering truncated BAFF receptors
09/02/2014CA2776242C Phenyloxadiazole derivatives as pgds inhibitors
09/02/2014CA2413866C Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations
08/2014
08/28/2014WO2014131023A1 Neoseptins: small molecule adjuvants
08/28/2014WO2014130947A1 Pyrazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators
08/28/2014WO2014130921A1 Particle formulations for delivery of tlr agonists and antigens
08/28/2014WO2014130908A1 Methods for treatment of ophthalmic diseases and disorders
08/28/2014WO2014130693A1 Inhibitors of bruton's tyrosine kinase
08/28/2014WO2014130550A1 Substituted diaryl derivatives as sphingosine receptor modulators
08/28/2014WO2014129914A1 Methods of treatment
08/28/2014WO2014129796A1 Sphingosine-1-phosphate receptor agonists, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
08/28/2014WO2014128655A1 Substituted imidazo[4,5-c]quinoline derivatives as bromodomain inhibitors
08/28/2014WO2014128612A1 Quinazolin-4-one derivatives
08/28/2014WO2014128611A1 Treatment of graft versus host disease in transplant patients
08/28/2014WO2014128591A1 Pyrrolo [2, 3 -d]pyrimidine derivatives as inhibitors of janus- related kinases (jak)
08/28/2014WO2014128585A1 Azabenzimidazole compounds as inhibitors of pde4 isozymes for the treatment of cns and other disorders
08/28/2014WO2014128225A1 Activation of inkt cells
08/28/2014WO2014128168A1 Anti-cd26 antibodies and uses thereof
08/28/2014WO2014128093A1 Substituted-imidazo[1,2-b]pyridazines as mknk1 inhibitors
08/28/2014WO2014127478A1 Vaccine composition
08/28/2014US20140243513 Methods for the Production of 3-O-Deactivated-4'-Monophosphoryl Lipid A (3D-MLA)
08/27/2014EP2769993A1 Antibodies against human NKG2D and uses thereof
08/27/2014EP2769992A2 High affinity human antibodies to human IL-4 receptor
08/27/2014EP2769976A1 Hydroxamic acid compound containing quinolyl and preparation method thereof, and pharmaceutical composition containing this compound and use thereof
08/27/2014EP2769738A1 Conjugated TLR7 and/or TLR8 and TLR2 polycationic agonists
08/27/2014EP2769731A1 Methods to activate or block the HLA-E/QA-1 restricted CD8+ T cell regulatory pathway to treat immunological disease
08/27/2014EP2769715A2 Methods for treating autoimmune disorders, and reagents related thereto
08/27/2014EP2769713A1 Solid oral composition comprising a S1P receptor agonist and a sugar alcohol
08/27/2014EP2768860A1 Antibodies directed against the alpha chain of il7 receptor - their use for the preparation of drug candidates
08/27/2014EP2768813A1 Quinazoline derivatives as pi3k modulators
08/27/2014EP2768494A1 Dosage regimen for an s1p receptor modulator or agonist
08/26/2014US8815821 Double-stranded oligonucleotides
08/26/2014US8815801 Controlled release composition and method of producing the same
08/26/2014US8815268 Oat extracts: refining, compositions and methods of use
08/26/2014US8815251 Microbial delivery system
08/26/2014CA2584295C Spiro-2, 4-pyrimidinediamine compounds and their uses
08/21/2014WO2014126932A1 Alkyne derivatives as sphingosine 1-phosphate (s1p) receptor modulators
08/21/2014WO2014126267A1 Difluprednate emulsion composition containing antimicrobial metal
08/21/2014WO2014126266A1 Difluprednate emulsion composition containing zinc
08/21/2014WO2014125444A1 Heterocyclic amides as kinase inhibitors
08/21/2014WO2014125052A1 Pharmaceutical composition for oral administration comprising fexofenadine and process for preparing thereof
08/21/2014WO2014125013A1 D-fagomine for the control of inflammatory processes related to an overactivation of the humoral immune response
08/21/2014WO2014096388A3 Novel benzimidazole derivatives as kinase inhibitors
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 ... 1172